These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1337 related articles for article (PubMed ID: 12431323)
41. [Conservative treatment of infiltrating cancer of the bladder: neoadjuvant chemotherapy and radiotherapy]. Prié L; Gaston R; Ferrière JM; Richaud P; Bui BN; Guillou ML Cancer Radiother; 1998 Apr; 2 Suppl 1():62s-66s. PubMed ID: 9749081 [TBL] [Abstract][Full Text] [Related]
42. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy. Lehmann J; Retz M; Stöckle M World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897 [TBL] [Abstract][Full Text] [Related]
43. Preoperative and postoperative adjuvant chemotherapy using CISCA (cyclophosphamide, doxorubicin, and cisplatin) in the treatment of invasive transitional-cell carcinoma of the bladder. Lynch DF Urol Clin North Am; 1991 Aug; 18(3):543-6. PubMed ID: 1877118 [TBL] [Abstract][Full Text] [Related]
44. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract. Koch MO; Coussens D Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122 [No Abstract] [Full Text] [Related]
45. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results. Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058 [TBL] [Abstract][Full Text] [Related]
46. [Neoadjuvant chemotherapy for invasive bladder cancer]. Kageyama Y; Kihara K Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476 [TBL] [Abstract][Full Text] [Related]
47. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy. Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495 [TBL] [Abstract][Full Text] [Related]
49. Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer. Bajorin DF J Clin Oncol; 2001 Sep; 19(18 Suppl):17S-20S. PubMed ID: 11560966 [No Abstract] [Full Text] [Related]
50. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer. Birtle AJ; Huddart RA BJU Int; 2006 Jun; 97(6):1348; author reply 1348-50. PubMed ID: 16686740 [No Abstract] [Full Text] [Related]
51. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer. Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929 [TBL] [Abstract][Full Text] [Related]
52. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer]. Miyanaga N; Akaza H Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008 [TBL] [Abstract][Full Text] [Related]
53. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only. de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076 [TBL] [Abstract][Full Text] [Related]
54. Neoadjuvant treatment for invasive bladder cancer: is it worthwhile? Hall RR Acta Urol Belg; 1996 May; 64(2):39-42. PubMed ID: 8701809 [No Abstract] [Full Text] [Related]
55. [A case report of a young patient with invasive bladder cancer]. Nakashima M; Nishiyama H; Yagihashi Y; Yamamoto S; Kamoto T; Habuchi T; Ogawa O Hinyokika Kiyo; 2003 Dec; 49(12):745-8. PubMed ID: 14978958 [TBL] [Abstract][Full Text] [Related]
56. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135 [TBL] [Abstract][Full Text] [Related]
57. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma. Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565 [TBL] [Abstract][Full Text] [Related]